Ozturk, M. Et Al. 2016. Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test. European Journal of Gynaecological Oncology , vol.37, no.2 , 232-237.

Ozturk, M., UMUDUM, H., Aydin, A., Ulubay, M., Keskin, U., Dede, M., ... Yenen, M.(2016). Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test. European Journal of Gynaecological Oncology , vol.37, no.2, 232-237.

Ozturk, M. Et Al. "Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test," European Journal of Gynaecological Oncology , vol.37, no.2, 232-237, 2016

Ozturk, M. Et Al. "Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test." European Journal of Gynaecological Oncology , vol.37, no.2, pp.232-237, 2016

Ozturk, M. Et Al. (2016) . "Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test." European Journal of Gynaecological Oncology , vol.37, no.2, pp.232-237.

@article{article, author={M. Ozturk Et Al. }, title={Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test}, journal={European Journal of Gynaecological Oncology}, year=2016, pages={232-237} }